---
title: "Antiseizure Medication Administration Gaps at ICU-to-Floor Transfer: Matched Within-Patient Study"
id: "medrxiv-5-antiseizure-medication-administration-gaps-across-the-icu-to-floor-transfer-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-5-antiseizure-medication-administration-gaps-across-the-icu-to-floor-transfer-a"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Antiseizure Medication Administration Gaps at ICU-to-Floor Transfer: Matched Within-Patient Study
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-5-antiseizure-medication-administration-gaps-across-the-icu-to-floor-transfer-a
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective cohort study used MIMIC‑IV (v3.1) data to quantify **antiseizure medication** (ASM) administration gaps occurring at the **ICU-to-floor transfer**. - Included admissions had epilepsy or status epilepticus, an ICU stay followed by transfer to a floor, and a scheduled ASM order active at ICU departure. - A gap was defined as an interval >1.5 times the expected dosing interval between the last ICU dose and first floor dose, or no further dose before discharge. - The analysis compared each transfer interval with a matched non‑transfer control interval in the same patient and drug (paired within‑patient comparison using McNemar test). - Among 2,469 ASM transition-by-drug observations from 1,583 admissions (1,335 patients), 251 gaps occurred (10.2%; 95% CI 8.7%–11.7%). - Transfer-associated gap frequency exceeded matched non‑transfer intervals by a paired rate difference of 5.8 percentage points before transfer (7.5% vs 1.7%; P = 7.3 × 10^-22) and 6.4 percentage points after transfer (8.9% vs 2.5%; P = 1.9 × 10^-23). - Gap rates were similar between IV‑available drugs (9.9%) and oral‑only drugs (11.4%); the difference was not statistically significant (rate difference 1.5 percentage points; 95% CI, −1.6 to 4.5; P = .34). - A multivariable model tested six prespecified clinical predictors; none remained significant after correction. - Authors conclude that administration gaps occur in roughly 1 in 10 drug‑transition observations at ICU‑to‑floor transfer and that the excess gap rate is associated with the transfer itself rather than a single medication or patient characteristic. - The findings support implementing a structured medication‑continuity check at the ICU‑to‑floor transition to reduce ASM interruptions.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=ptJ1.MIw.Zg3t8c4bbnVi5M8L.47bqFoyxLPxzr_2es-1788216161.0252647-1.2.1.1-WdgkBlTYynXUEJERLKY5N.xfCXfwcfcIuuAXwkw2OrbHP6KQSHaLljeZXVtIbm8w) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Antiseizure Medication Administration Gaps Across the ICU-to-Floor Transfer: A Matched Within-Patient Comparison Alon Gorenshtein, Yosef Adiniaev, Amir Srour, Eyal Klang, Oved Daniel doi: https://doi.org/10.64898/2026.08.26.26361462 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Alon Gorenshtein 1 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alon%2BGorenshtein%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gorenshtein%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlon%2BGorenshtein%2B) * For correspondence: alon323@hotmail.com Yosef Adiniaev 2 BRIDGE GenAI Lab, Beth Israel Deaconess Medical Center, Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yosef%2BAdiniaev%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Adiniaev%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYosef%2BAdiniaev%2B) Amir Srour 2 BRIDGE GenAI Lab, Beth Israel Deaconess Medical Center, Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Amir%2BSrour%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Srour%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAmir%2BSrour%2B) Eyal Klang 2 BRIDGE GenAI Lab, Beth Israel Deaconess Medical Center, Boston, MA, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Eyal%2BKlang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Klang%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEyal%2BKlang%2B) Oved Daniel 3 Neurology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Oved%2BDaniel%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Daniel%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AOved%2BDaniel%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289267/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289267/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289267/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1289267/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289267/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289267/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective: Whether a scheduled antiseizure medication (ASM) continues on schedule across the ICU-to-floor transfer has not been characterized. We quantified ASM administration-gap frequency across this transfer and compared it with gap frequency during matched non-transfer intervals in the same patient and drug. Methods: In this retrospective MIMIC-IV (version 3.1) cohort study, we identified epilepsy and status-epilepticus admissions with an ICU stay followed by floor transfer and a scheduled ASM order active at ICU departure. A gap was defined as an interval exceeding 1.5 times the expected dosing interval between the last ICU dose and first floor dose, or no further dose before discharge, and compared with a matched non-transfer control interval in the same patient and drug (paired McNemar test). A multivariable model evaluated six prespecified clinical predictors; sociodemographic variables were summarized descriptively. Results: Among 2,469 ASM transition-by-drug observations (1,583 admissions, 1,335 patients), an administration gap occurred in 251 (10.2%; 95% CI, 8.7%-11.7%). Gap frequency across the transfer exceeded frequency during matched non-transfer control intervals in the same patient and drug: a paired rate difference of 5.8 percentage points (95% CI, 4.4-7.1; 7.5% vs 1.7%; P = 7.3 x 10^-22) before the transfer and 6.4 percentage points (95% CI, 4.9-7.9; 8.9% vs 2.5%; P = 1.9 x 10^-23) after. Gap rates were similar for intravenous-available (9.9%) and oral-only (11.4%) drugs (rate difference, 1.5 percentage points; 95% CI, -1.6 to 4.5; P = .34). None of six prespecified predictors reached significance after correction. Significance: An antiseizure medication administration gap occurred in approximately 1 of every 10 drug-transition observations at the ICU-to-floor transfer, exceeding matched non-transfer gap rates by 5.8 to 6.4 percentage points. This transfer-associated excess, rather than any single medication or patient characteristic, supports a structured medication-continuity check. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Board at the Beth Israel Deaconess Medical Center waived ethical approval for this work. The collection of patient information and creation of the MIMIC-IV research resource was reviewed by the Institutional Review Board at the Beth Israel Deaconess Medical Center, which granted a waiver of informed consent and approved the data sharing initiative. The present study is a secondary analysis of that deidentified, credentialed-access resource, conducted under the PhysioNet data use agreement following completion of the required human-subjects research training by the investigators. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data analyzed in the present study are derived from MIMIC-IV (version 3.1), which is publicly available to credentialed users through PhysioNet (https://physionet.org). Access requires completion of the required human-subjects research training and acceptance of the PhysioNet data use agreement. The analysis code is available at https://github.com/Alon-Gorenshtein/ASM_Continuity. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.26.26361348v1 "Burr-Hole Intersection of Middle Meningeal Artery Branches and Recurrence in Chronic Subdural Haematoma: a Multicentre Retrospective Cohort Study")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.27.26361567v1 "Longitudinal Tracking and Construct Validity of a Single-Item Physical Activity Measure in the Womens Healthy Ageing Project") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.26.26361462.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.26.26361462v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.26.26361462.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Antiseizure Medication Administration Gaps Across the ICU-to-Floor Transfer: A Matched Within-Patient Comparison Alon Gorenshtein, Yosef Adiniaev, Amir Srour, Eyal Klang, Oved Daniel medRxiv 2026.08.26.26361462; doi: https://doi.org/10.64898/2026.08.26.26361462 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.26.26361462v1%26text%3DAntiseizure%2520Medication%2520Administration%2520Gaps%2520Across%2520the%2520ICU-to-Floor%2520Transfer%253A%2520A%2520Matched%2520Within-Patient%2520Comparison "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.26.26361462v1%26t%3DAntiseizure%2520Medication%2520Administration%2520Gaps%2520Across%2520the%2520ICU-to-Floor%2520Transfer%253A%2520A%2520Matched%2520Within-Patient%2520Comparison "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.26.26361462v1%26title%3DAntiseizure%2520Medication%2520Administration%2520Gaps%2520Across%2520the%2520ICU-to-Floor%2520Transfer%253A%2520A%2520Matched%2520Within-Patient%2520Comparison%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.26.26361462v1%26title%3DAntiseizure%2520Medication%2520Administration%2520Gaps%2520Across%2520the%2520ICU-to-Floor%2520Transfer%253A%2520A%2520Matched%2520Within-Patient%2520Comparison "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.26.26361462) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.26.26361462v1&count=horizontal&via=&text=Antiseizure%20Medication%20Administration%20Gaps%20Across%20the%20ICU-to-Floor%20Transfer%3A%20A%20Matched%20Within-Patient%20Comparison&counturl=www.medrxiv.org/content/10.64898/2026.08.26.26361462v1 "Tweet This") ## Subject Area * [Neurology ](https://www.medrxiv.org/collection/neurology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4765) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (641) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1612) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15826) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6979) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1056) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4968) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1424) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1733) * [Hematology](https://www.medrxiv.org/collection/hematology) (579) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1333) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16239) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1160) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (720) * [Neurology](https://www.medrxiv.org/collection/neurology) (7186) * [Nursing](https://www.medrxiv.org/collection/nursing) (363) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1072) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1230) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (999) * [Oncology](https://www.medrxiv.org/collection/oncology) (3567) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1035) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (465) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1772) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (732) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5827) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9680) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2384) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1431) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1239) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (633) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (765) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (574) * [Surgery](https://www.medrxiv.org/collection/surgery) (766) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (302) * [Urology](https://www.medrxiv.org/collection/urology) (285) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface pow
## Related Clinical Research

- [Cognitive Trajectories After Traumatic Brain Injury and Links to Post‑Traumatic Epilepsy Risk](https://medichelpline.com/clinical-feed/medrxiv-0-evaluating-cognitive-impact-of-traumatic-brain-injury-and-risk-for-post.md)
- [White Matter Microstructure Changes in Functional Motor Disorder: Diffusion MRI Findings](https://medichelpline.com/clinical-feed/medrxiv-11-white-matter-microstructural-alterations-and-symptom-correlates-in-functional.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [FI-Lab: Automated laboratory-based frailty index for acute care and its prognostic performance](https://medichelpline.com/clinical-feed/plos-medicine-3-evaluation-of-the-fi-lab-a-laboratory-based-automated-frailty-index-for-acute.md)
- [Moderna and Merck’s cancer vaccine algorithm: what’s known and why it matters](https://medichelpline.com/clinical-feed/stat-news-1-what-s-in-merck-and-moderna-s-cancer-vaccine-algorithm.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.